info@synchemia.com | sales@synchemia.com 
9766925136 
Home
>
API Impurities
>
Nitroso
>
N-Nitroso Oxetacaine Stage D | N-methyl-N-(2-methyl-1-phenylpropan-2-yl)nitrous amide
N-Nitroso Oxetacaine Stage D | N-methyl-N-(2-methyl-1-phenylpropan-2-yl)nitrous amide
Synchemia is a leading Manufacturer in pharmaceutical Nitrosamine compounds.N-Nitroso Oxetacaine Stage D can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Nitrosamines .N-Nitroso Oxetacaine Stage D is a highly toxic organic compound and a suspected human carcinogen. Handle the material carefully with proper safety measures.
N-Nitroso Oxetacaine Stage D CAS NO: NA Chemically represented as N-methyl-N-(2-methyl-1-phenylpropan-2-yl)nitrous amide.Synchemia is the leading manufacturing and exporter of N-Nitroso Oxetacaine Stage D .We supply N-Nitroso Oxetacaine Stage D with detailed characterization data compliance with regulatory guidelines.
Related Products
| CAT No | SRC-N0143411 |
| CAS No | NA |
| Mol.F. | C23H22F2N6O3 |
| Mol.Wt. | 468.46 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143412 |
| CAS No | NA |
| Mol.F. | C24H24F2N6O3 |
| Mol.Wt. | 482.19 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143413 |
| CAS No | NA |
| Mol.F. | C29H32F2N6O5 |
| Mol.Wt. | 582.61 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143414 |
| CAS No | NA |
| Mol.F. | C23H25BF2N2O4 |
| Mol.Wt. | 442.27 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143415 |
| CAS No | NA |
| Mol.F. | C26H24F2N6O4 |
| Mol.Wt. | 522.51 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143416 |
| CAS No | NA |
| Mol.F. | C21H22N2O5S |
| Mol.Wt. | 414.48 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143417 |
| CAS No | NA |
| Mol.F. | C12H14N2O4S |
| Mol.Wt. | 282.31 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143418 |
| CAS No | NA |
| Mol.F. | C14H16N2O5S |
| Mol.Wt. | 324.35 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143419 |
| CAS No | NA |
| Mol.F. | C24H27N3O7S2 |
| Mol.Wt. | 533.61 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143420 |
| CAS No | NA |
| Mol.F. | C19H20N2O4S |
| Mol.Wt. | 372.44 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143421 |
| CAS No | NA |
| Mol.F. | C38H39N3O7S2 |
| Mol.Wt. | 713.86 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143422 |
| CAS No | NA |
| Mol.F. | C19H18N2O4 |
| Mol.Wt. | 338.36 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143423 |
| CAS No | NA |
| Mol.F. | C13H16N2O4S |
| Mol.Wt. | 296.34 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143424 |
| CAS No | NA |
| Mol.F. | C15H18N2O5S |
| Mol.Wt. | 338.38 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143425 |
| CAS No | NA |
| Mol.F. | C21H22N2O6S |
| Mol.Wt. | 430.48 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143426 |
| CAS No | NA |
| Mol.F. | C18H22N2O4 |
| Mol.Wt. | 330.38 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
